OLAYINKA OLASIMBO: Open Payments
NPI 1467726760 · TIMONIUM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$158 in 7 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $158
Food & beverage: $158
| Company | Payments | Amount |
|---|---|---|
| SANOFI PASTEUR INC. | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Lilly USA, LLC | 1 | $24 |
| Exact Sciences Corporation | 1 | $22 |
| Novo Nordisk Inc | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $17 |
Products named: FLUZONE HIGH-DOSE, CAPVAXIVE, MOUNJARO, The Cologuard Plus Collection Kit, Ozempic, AIRSUPRA, LifeVest.
Industry payments across MD — which companies pay providers there.
